Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
Completed · Phase 3
Conditions studied: Breast Cancer
In brief
This was a multi-center, multinational, randomized, open-label, Phase III study comparing combination taxane-based chemotherapy plus lapatinib to combination taxane-based chemotherapy plus trastuzumab in women with documented evidence of human epidermal growth factor receptor 2 (HER2) positive metastatic breast cancer (MBC) (by local or central laboratory testing) who had received no prior chemotherapy or HER2 targeted therapy in the metastatic setting.
Key facts
- Study ID
- NCT00667251
- Run by
- Novartis Pharmaceuticals
- People needed
- 652
- Starts
- 2008-10-07
- Expected to finish
- 2022-07-27
- Last updated by the study team
- 2025-03-21
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Tucson, Arizona, United States
- Novartis Investigative Site — Hot Springs, Arkansas, United States
- Novartis Investigative Site — Berkeley, California, United States
- Novartis Investigative Site — Highland, California, United States
- Novartis Investigative Site — Montebello, California, United States
- Novartis Investigative Site — Colorado Springs, Colorado, United States
- Novartis Investigative Site — Denver, Colorado, United States
- Novartis Investigative Site — Greenwich, Connecticut, United States
- Novartis Investigative Site — Southington, Connecticut, United States
- Novartis Investigative Site — Stamford, Connecticut, United States
- Novartis Investigative Site — Trumbull, Connecticut, United States
- Novartis Investigative Site — Waterbury, Connecticut, United States
- Novartis Investigative Site — Kissimmee, Florida, United States
- Novartis Investigative Site — Loxahatchee Groves, Florida, United States
- Novartis Investigative Site — New Port Richey, Florida, United States
- Novartis Investigative Site — Augusta, Georgia, United States
- Novartis Investigative Site — Lawrenceville, Georgia, United States
- Novartis Investigative Site — Savannah, Georgia, United States
- Novartis Investigative Site — Post Falls, Idaho, United States
- Novartis Investigative Site — Chicago, Illinois, United States
- Novartis Investigative Site — Oak Lawn, Illinois, United States
- Novartis Investigative Site — Evansville, Indiana, United States
- Novartis Investigative Site — Goshen, Indiana, United States
- Novartis Investigative Site — Indianapolis, Indiana, United States
- Novartis Investigative Site — Anchorage, Alaska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.